ALDH1A1 and neoplasm: Notably, the tumorigenicity of the sorted CD133+ALDH1+ LoVo cells was enhanced and fewer implantation of 1 × 105, 1 × 104, 1 × 103, or 1 × 102 cells were needed, meanwhile tumor size and tumorigenicity were quelled by FUBP1‐silence (Fig. 4E,F; Table S4).